Although CD69+ S1+RBD+ BSM were noted post-infection and post-vaccination, the percentage of CD69+ cells among S1+RBD+ BSM was significantly higher in INF tonsils compared to VAC (Figure 4f). This evidence concerns the gene CD69 and infection.